Taro-Doxorubicin Liposomal recall in Canada: product quality
In plain language
This recall involves Taro-Doxorubicin Liposomal sold in Canada. It's being recalled because it may contain particulate matter. Consult your healthcare provider if you have this product.
What to do
- Consult your healthcare provider prior to discontinuing use.
- Contact the recalling firm with any questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Taro Doxorubicin Liposomal
Lot: HAF1937A
Why this matters
Product quality issue
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: HAF1937A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality issue
What should consumers do?
Consult your healthcare provider prior to discontinuing use. Contact the recalling firm with any questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality issue
When was this product recalled?
This product was recalled on July 11, 2025.
Is the Taro-Doxorubicin Liposomal brand affected by this recall?
Yes, Taro-Doxorubicin Liposomal products are affected by this recall. This recall involves Taro-Doxorubicin Liposomal sold in Canada. It's being recalled because it may contain particulate matter. Consult your healthcare provider if you have this product.